Functional and morphological cardiac changes in myeloproliferative disorders (clinical study)

International Journal of Cardiology

Volumn 97, Issue 2, 2004, Pages 213-220

  Kadikoylu, Gurhan ^a   Onbasili, Alper ^a   Tekten, Tarkan ^a   Barutca, Sabri ^a   Bolaman, Zahit ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Cardiac lesions; Echocardiography; Myeloproliferative disorders

Indexed keywords

ADULT; AGED; ARTICLE; CALCIFICATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART VALVE REGURGITATION; HUMAN; MALE; MITRAL VALVE REGURGITATION; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; THROMBOCYTHEMIA; THROMBOEMBOLISM; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HEART VALVE DISEASES; HEART VALVES; HEART VENTRICLES; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; MYELOPROLIFERATIVE DISORDERS; THROMBOCYTOSIS; THROMBOEMBOLISM;

EID: 4644275172     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.08.013     Document Type: Article

References (46)

1. Larson R.S., Wolff S.N. Chronic myeloid leukemia. Lee G.R., Foerster J., Lukens J., Paraskevas F., Greer J.P., Rodgers G.M. Wintrobe's clinical hematology. 10th ed. :1999;2342-2375 Williams-Wilkins, Maryland
2. Broodmann S., Passweg J.R., Gratwohl A., Tichelli A., Skoda R.C. Myeloproliferative disorders: complications, survival and causes of death. Ann. Hematol. 79:2000;312-318
3. Sagripanti A., Ferretti A., Nicoloni A., Carpi A. Thrombotic and hemorrhagic complications in chronic myeloproliferative disorders. Biomed. Pharmacother. 50:1996;376-382
4. Gruppo Italiano Studio Policitemia. Polycythemia vera: the natural history of 1213 patients followed for 20 years. Ann. Intern. 123:1995;656-664
5. Wehmeier A., Daum I., Jamin H., Schneider W. Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders: a retrospective analysis of 260 patients. Ann. Hematol. 63:1991;101-106
6. Barbui T., Cortelazzo S., Vierro P., Bassan R., Dini E., Semeraro N. Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function. Eur. J. Cancer Clin. Oncol. 19:1983;1593-1599
7. Cortelazzo S., Viero P., Finazzi G., D'Emili O., Rodeghiero F., Barbui T. Incidence and risk factors for thrombotic complications in historical cohort of 100 patients with essential thrombocythemia. J. Clin. Oncol. 8:1990;556-562
8. Watson K.V., Key N. Vascular complications of essential thrombocythemia: a link to cardiovascular risk factors. Br. J. Haematol. 83:1993;198-203
9. Nand S., Orfei E. PHT in polycythemia vera. Am. J. Hematol. 47:1994;242-244
10. Garcia-Manero G., Schuster S.J., Patrick H., Martinez J. PHT in patients with myelofibrosis secondary to myeloproliferative diseases. Am. J. Hematol. 60:1999;130-135
11. Koh K.H., Cho S.K., Kim S.S., Oh B.H., Lee Y.W. Coronary vasospasm, multiple coronary thrombosis, unstable angina and essential thrombocytosis. Int. J. Cardiol. 41:1993;168-170
12. Mohapatara M.K., Das S.P., Mohanty N.C., Dash P.C., Bastia B.K. Haemopericardium with cardiac tamponade and pleural effusion in chronic myeloid leukemia. Indian Heart J. 52:2000;209-211
13. Ali M., Fayemi A.O., Malcolm D., Braun E.V., Teaneck N.J. Intraventricular thrombosis in polycythemia vera: a cause of intractable cardiac failure. Am. Heart J. 100:1980;520-522
14. Matsuyama N., Asada K., Kondo K., Kodama T., Minohara S., Hasegawa S., et al. Surgical treatment of aortic stenosis with polycythemia vera: a case report. Kyobu Geka. 49:1996;1097-1099
15. Nonami Y., Sasahashi N., Satoh K., Ogpshi S., Tamiya T. A case report: mitral valve replacement for the patient with essential thrombocythemia. Nippon Kyobu Geka Gakkai Zasshi. 41:1993;1567-1572
16. Reisner S., Rinkevich D., Markiewicz W., Tatarsky I., Brenner B. Cardiac involvement in patients with myeloproliferative disorders. Am. J. Med. 93:1992;498-504
17. Pearson T.C. Evaluation of diagnostic criteria in polycythemia vera. Semin. Hematol. 38:(1 Suppl. 2):2001;21-24
18. Murphy S., Peterson P., Iland H., Rosenthal D., Laszlo J. Essential thrombocythemia: an interim report from the polycythemia vera study group. Semin. Hematol. 23:1986;177-182
19. Rupoli S., Da Lio L., Sisti S., Campanati G., Salvi A., Brianzoni M.F., et al. Primary myelofibrosis: a detailed statistical analysis of the clinicopathological variables influencing survival. Ann. Hematol. 68:1994;205-212
20. Henry W.L., DeMaria A., Gramiak R., King D.L., Kisslo J.A., Popp R.L., et al. Report of the American Society of Echocardiography Committee on nomenclature and standards in two dimensional echocardiography. Circulation. 62:1980;212-217
21. Chirillo F., Bruni A., Giujusa T., Totis O., Cavarzerani A., Stritoni P. Echocardiography in infective endocarditis: reassessment of the diagnostic criteria of vegetation as evaluated from the precordial and transesophageal approach. Am. J. Card. Imaging. 9:1995;174-179
22. Spain M.G., Smith M.D., Grayburn P.A., Harlamert E.A., DeMaria A.N. Quantitative assessment of mitral regurgitation by Doppler color flow imaging: angiographic and hemodynamic correlations. J. Am. Coll. Cardiol. 13:1989;585-590
23. Kandath D., Nanda N.C. Assessment of aortic regurgitation by noninvasive techniques. Curr. Probl. Cardiol. 15:1990;45-58
24. Berger M., Haimowitz A., Van Tosh A., Berdoff R.L., Goldberg E. Quantitative assessment of PHT in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J. Am. Coll. Cardiol. 6:1985;359-365
25. Otto C.M., Pearlman A.S. Textbook of clinical echocardiography. 1st ed. :1995;117-127 W.B. Saunders Company, Philadelphia
26. Roldan C.A., Shively B.K., Crawford M.H. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. New Engl. J. Med. 335:1996;1424-1430
27. Otto C.M., Pearlman A.S. The role of echocardiography in suspected or definite endocarditis. Textbook of clinical echocardiography. 1st ed. :1995;305-322 W.B. Saunders Company, Philadelphia
28. Weyman A.E. Miscellaneous echocardographic techniques: II. Transesophageal echocardiography. Principles and practice of echocardiography. 2nd ed. :1994;327 Lea and Febiger, Philadelphia
29. Weyman A.E. Principles and practice of echocardiography. 2nd ed. :1994;509 Lea and Febiger, Philadelphia
30. Singh J.P., Evans J.C., Levy D., Larson M.G., Freed L.A., Fuller D.L., et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am. J. Cardiol. 83:1999;897-902
31. Biava G., Delfino M., Lagana B., Urani C., Camera A., Modica M., et al. Prevalence of valvular regurgitation in structurally normal hearts: a colour-Doppler study. Coron. Artery Dis. 8:1997;559-563
32. Otto C.M., Pearlman A.S. Textbook of clinical echocardiography. 1st ed. :1995;247 W.B. Saunders Company, Philadelphia
33. Yoshida K., Yoshikawa J., Shakudo M., Akasaka T., Jyo Y., Takao S., et al. Color Doppler evaluation of valvular regurgitation in normal subjects. Circulation. 78:1988;840-847
34. Jobic Y., Slama M., Tribouilloy C., Lan Cheong Wah L., Choquet D., Boschat J., et al. Doppler echocardiographic evaluation of valve regurgitation in healthy volunteers. Br. Heart J. 69:1993;109-113
35. Sekino Y., Suzuki Y., Sato N., Sadahiro M., Mohri H. Open heart surgery in a patient with chronic leukemia. Nippon Geka Gakkai Zasshi. 90:1989;450-453
36. Dingli D., Utz J.P., Krowka M.J., Oberg A.L., Tefferi A. Unexplained pulmonary hypertension in chronic myeloproliferative disorders. Chest. 120:2001;801-808
37. Hill G., McLean D., Fraser R., Hart D., Crozier I., Snowden J., et al. Pulmonary hypertension as a sequence of alveolar capillary plugging by malignant megakaryocytes in essential thrombocythemia. Aust. New Zealand J. Med. 26:1996;852-853
38. Marvin K.S., Spellberg R.D. Pulmonary hypertension secondary to thrombocytosis in a patient with myeloid metaplasia. Chest. 103:1993;642-644
39. Rostagno C., Prisco D., Abbate R., Poggesi L. Pulmonary hypertension associated with longstanding thrombocytosis. Chest. 99:1991;1303-1305
40. Cervantes F., Pereira A., Esteve J., Cobo F., Rozman C., Montserrat E. Idiopathic myelofibrosis: initial features, evolutive patterns and survival in a series of 106 patients. Med. Clin. 109:1997;651-655
41. Lopez-Guillermo A., Cervantes F., Rovira M., Pereira A., Quinteros L., Rozman C. Idiopathic myelofibrosis: clinical course, survival and causes of death in a series of 60 patients. Sangre. 35:1990;114-118
42. Schafer A.I. Essential thrombocythemia. Prog. Hemost. Thromb. 10:1991;69-96
43. Shattil S.J., Abrams C.S., Bennett J.S. Acquired qualitative platelet disorders due to diseases, drugs, and foods. Beutler E., Lichtman M.A., Coller B.S., Kipps T.J., Seligsohn U. Williams hematology. 6th ed. :2001;1583-1603 McGraw Hill. International edition
44. Rossi C., Randi M.L., Zerbinati V., Girolami A. Acute coronary disease in essential thrombocythemia and polycythemia vera. J. Intern. Med. 244:1998;49-53
45. Lip G.Y., Li-Saw-Hee F.L. Does hypertension confer a hypercoagulable state? J. Hypertens. 16:1998;913-916
46. Lottermoser K., Weisser B., Hertfelder H.J., Wostmann B., Vetter H., Dusing R. Antihypertensive drug treatment and fibrinolytic function. Am. J. Hypertens. 11:1998;378-384